The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy

SIMPLE SUMMARY: Non-Small-Cell Lung Cancer (NSCLC) is the primary cause of cancer-related death worldwide. Patients carrying Epidermal Growth Factor Receptor (EGFR) mutations usually benefit from targeted therapy treatment. Nonetheless, primary or acquired resistance mechanisms lead to treatment dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Canale, Matteo, Andrikou, Kalliopi, Priano, Ilaria, Cravero, Paola, Pasini, Luigi, Urbini, Milena, Delmonte, Angelo, Crinò, Lucio, Bronte, Giuseppe, Ulivi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909869/
https://www.ncbi.nlm.nih.gov/pubmed/35267450
http://dx.doi.org/10.3390/cancers14051143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909869/
https://www.ncbi.nlm.nih.gov/pubmed/35267450
http://dx.doi.org/10.3390/cancers14051143

Ejemplares similares